Indaptus Therapeutics, Inc. ( INDP) - Stock Earnings
INDP Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Nov. 17, 2026, midnight | — / — | — | — / — | — |
INDP Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | -8.1 million USD | — USD |
| 2026Q1 | -2.5 million USD | — USD |
| 2026Q2 | -1.8 million USD | — USD |
| 2026Q4 Est. | — | — |
INDP Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -15.4 million USD | — USD |
| 2024 | -15.0 million USD | — USD |
| 2025 | -20.8 million USD | — USD |
| 2026 Est. | — | — |
INDP
Price: $3.34
52 week price:
Earnings Per Share: -3.36 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 19752
Market Capitalization: 269.5 million